Clinical and Preclinical Pharmacology Laboratory, National Cancer Research Centre Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy;
Medical Oncology Unit, National Cancer Research Centre Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy;
Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine University Hospital, 56126 Pisa, Italy;
Pharmacology Unit, National Cancer Research Centre Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy;
Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, China;
Radiology unit, National Cancer Research Centre Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy;
Medical Oncology Unit, 'Casa Sollievo della Sofferenza' Hospital, 71013 San Giovanni Rotondo, Italy;
Medical Oncology Unit, 'Mons R Dimiccoli' Hospital, 76121 Barletta, Italy;
Bevacizumab; Vascular; endothelial; growth; factor; Angiopoietin; 2; Metastatic; colorectal; cancer; Biomarker;